Related Experiment Video

Updated: Aug 11, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

[Homocysteine, a less well-known risk factor in cardiac and vascular diseases]

J Simon1, J Racek, H Rosolová

  • 1II. interní klinika LF UK a FN Plzen.

Casopis Lekaru Ceskych
|May 2, 1996
PubMed

Insights

High homocysteine (Hcy) levels are linked to vascular issues and cardiovascular disease. While vitamin supplements may lower Hcy, their impact on reducing cardiovascular events requires further clinical study.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Clinical Biochemistry

Context:

  • Hyperhomocysteinemia (Hcy) is associated with endothelial dysfunction and coagulation abnormalities.
  • Epidemiological studies link Hcy to premature arteriosclerosis, stroke, myocardial infarction, and peripheral vascular diseases, independent of conventional risk factors.
  • Pilot study demonstrated elevated Hcy levels in patients with ischemic heart disease compared to controls.

Purpose:

  • To investigate the association between homocysteine levels and ischemic heart disease.
  • To evaluate the potential role of homocysteine as a risk factor for cardiovascular diseases.
  • To underscore the need for further clinical and epidemiological studies on Hcy and cardiovascular outcomes.

Summary:

  • Hyperhomocysteinemia negatively impacts vascular endothelium and coagulation.
  • Clinical studies have proven the association of Hcy with premature arteriosclerosis, stroke, and other vascular diseases.
  • Vitamin supplementation (folates, B6, B12) can reduce Hcy levels, but its effect on cardiovascular disease incidence and mortality remains unproven.

Impact:

  • Highlights the clinical significance of hyperhomocysteinemia in cardiovascular pathology.
  • Emphasizes the need for further research into the therapeutic benefits of homocysteine-lowering strategies.
  • Provides a foundation for future clinical trials investigating homocysteine-targeted interventions for cardiovascular disease prevention.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...